SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001213900-13-005474
Filing Date
2013-09-30
Accepted
2013-09-30 17:30:11
Documents
14

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS f434b3093013_soligenix.htm 424B3 2086662
2 img001.jpg GRAPHIC 11884
3 img002.jpg GRAPHIC 386524
4 img003.jpg GRAPHIC 33079
5 img005.jpg GRAPHIC 12228
6 img006.jpg GRAPHIC 25539
7 img007.jpg GRAPHIC 69613
8 img002i.jpg GRAPHIC 189430
9 img003i.jpg GRAPHIC 52353
10 img004i.jpg GRAPHIC 53813
11 img005i.jpg GRAPHIC 17934
12 img006i.jpg GRAPHIC 22223
13 img007i.jpg GRAPHIC 36034
14 img008.jpg GRAPHIC 55302
  Complete submission text file 0001213900-13-005474.txt   3420293
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-184762 | Film No.: 131124240
SIC: 2834 Pharmaceutical Preparations